• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR® NEXT GEN; BLOOD GLUCOSE METER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR® NEXT GEN; BLOOD GLUCOSE METER Back to Search Results
Model Number 7922
Medical Device Problem Code Missing Test Results (3267)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/03/2025
Type of Reportable Event Malfunction
Event or Problem Description
The customer reported that his blood glucose readings were not being stored in the memory of the contour® next gen meter.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
No information was captured in section a4 as the customer's weight was not provided.The contour® next gen meter does not have an expiration date.Therefore, no information was captured in section d4 (expiration date).The warranty period of the meter is 5 years from the date of the original purchase.
 
Additional Manufacturer Narrative
The customer returned the suspected contour® next gen meter (serial # (b)(6)) for evaluation.No test strips were returned.Upon in-house investigation of the returned meter, it switched on as expected and no anomalies were observed when customer service mode was run.Three control tests were conducted using the returned meter, in-house contour® next test strips (lot # 3mheg02a) and in-house contour next control solution (lot # 5bv2g37) to check meter functionality.The results were 133 mg/dl, 130 mg/dl and 133 mg/dl, all within the expected control range of 113 mg/dl to 141 mg/dl.Additionally, an in-house testing was performed with the returned meter and in-house contour® next test strips (lot # 3mheg02a) using blood spiked with glucose at 133 mg/dl, as determined by ysi instrument in five replicates.All tests recovered within fit-for-use limits.The blood glucose results obtained with the in-house testing were properly stored in the meter's memory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR® NEXT GEN
Common Device Name
BLOOD GLUCOSE METER
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PT PHC INDONESIA (REGISTRATION NUMBER: 3009204541)
kawasan industri mm2100 blok o
cikarang barat bekasi
jawa barat, 17520
ID   17520
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key21504297
Report Number1810909-2025-00031
Device Sequence Number12764090
Product Code NBW
UDI-Device Identifier00301937922015
UDI-Public(01)00301937922015(17)280401(10)DM02T319P
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K223293
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 09/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model Number7922
Device Catalogue Number90010385
Device Lot NumberDM02T319P
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/03/2025
Supplement Date Received by Manufacturer09/03/2025
Initial Report FDA Received Date03/03/2025
Supplement Report FDA Received Date09/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/24/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient Age73 YR
Patient SexMale
-
-